Julian Beach

What Julian Beach has said

• “The UK has the ingredients to be a global leader in rare disease therapies, with a rich academic base, a single provider of genomics and the unique, diverse datasets of the NHS. The challenge is bringing all these elements together, which our new framework will do.”

  MHRA Executive Director, Healthcare Quality and Access · Rare diseases · 30 Sept 2026 · MHRA set to overhaul the UK’s rare disease drug regulatory pathway ↗

• “This approval marks the world's first authorisation of an inhaler using the next-generation propellant HFA-152a. It demonstrates how innovation can support both patient care and environmental sustainability while maintaining the high standards of quality, safety and effectiveness patients expect.”

  MHRA Executive Director of Healthcare Quality and Access · Respiratory (asthma/COPD) · 30 Sept 2026 · MHRA approves world's first lower-carbon beclometasone inhalers for patients with asthma ↗

• “These conditions affect a significant number of people across the UK, and in some cases can be difficult to manage despite existing treatments. This approval represents another potential treatment option for patients living with some forms of these conditions whose symptoms have not been adequately controlled with current therapies.”

  MHRA Interim Executive Director, Healthcare Quality and Access · Respiratory (asthma/COPD) · 30 Sept 2026 · UK approves the first twice yearly biological medicine for asthma and severe chronic rhinosinusitis with nasal polyps ↗

• “Leaving the jurisdiction of the PMCPA does not mean a company escapes scrutiny. The MHRA has legal powers … to investigate and act on concerns about medicines that may impact public safety.”

  MHRA's executive director of healthcare quality and access · Women's health & gynaecology · 30 Sept 2026 · HRT maker censured by UK regulator for ‘systemic failures’ that put patients at risk ↗

• “We're assured that the appropriate regulatory standards for the approval of this medicine have been met and, as with all medicines, we will keep its safety under close review.”

  MHRA executive director of healthcare quality and access · Heart disease & stroke · 10 Sept 2026 · New pill for heart condition receives simultaneous NICE and MHRA approval ↗

Where Julian Beach has been quoted

1. MHRA consults on new regulatory framework to make UK a global leader in rare disease therapy developmentgov.uk · 30 Sept 2026
2. MHRA set to overhaul the UK’s rare disease drug regulatory pathwayeuropeanpharmaceuticalreview.com · 30 Sept 2026
3. MHRA approves world's first lower-carbon beclometasone inhalers for patients with asthmagov.uk · 30 Sept 2026
4. UK approves the first twice yearly biological medicine for asthma and severe chronic rhinosinusitis with nasal polypsgov.uk · 30 Sept 2026
5. HRT maker censured by UK regulator for ‘systemic failures’ that put patients at risktheguardian.com · 30 Sept 2026
6. New pill for heart condition receives simultaneous NICE and MHRA approvalpulsetoday.co.uk · 10 Sept 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

• Britain’s top gynaecologist: ‘Women outlive men, but at a cost to their health’The Telegraph
• For years, the wife of the rugby league icon shared the realities of living with MNDFacebook
• BioMarin Pharmaceutical (BMRN) Flags 13 ASBMR Studies, Is It 25% Undervalued?Simply Wall Street